Our Team

View Simon’s Recommendations, Articles, and Videos

Simon Erickson is the founder and CEO of 7investing. He is one of the stock market’s most forward-looking investors, focused on identifying disruptive innovation and finding developing trends before others may even be aware of them.

He does this by traveling often to industry conferences and by speaking directly with business, scientific, and academic leaders ─ to learn firsthand about the cutting-edge technologies impacting the business world.

That included a conversation in 2014 with a Harvard postdoc about a new scientific breakthrough called “CRISPR”. And then a trip in 2015 to NVIDIA’s Silicon Valley headquarters to learn about a new field of “deep learning.”

But he also personally dives in to these developing trends. He’s been plugged-in to immersive virtual reality, rode in the beta-version of Waymo’s self-driving car, bought his first Bitcoin for just $247, and took a pharmacogenomic DNA test to explain how he’d react to prescription drugs.

Simon previously worked for seven years at The Motley Fool, where he most recently served as the lead advisor of Motley Fool Explorer. In this role, Simon ran an investment newsletter that profiled innovative trends, personally directed more than $1 million of funds into a real-money investment account, and managed a team of 22 people. Explorer was recognized as one of TMF’s fastest-growing and highest customer retention newsletters.

Simon has also been active in the financial media, offering his opinion of Facebook’s 10-year plan to CNN, discussing Alphabet’s “other bets” to CNBC, and sharing his thoughts about innovation and investing to podcasts and newspapers across America. He has a BS in Chemical Engineering from the University of Texas at Austin and an MBA in Entrepreneurship from Rice University in Houston. In his spare time, he enjoys traveling, listening to rock music, and spending time with his wife, daughter, and son. He has now watched Frozen approximately 43 million times.

Simon brings a passion of digging into developing trends to uncover opportunities for 7investing. He believes personalized medicine and machine learning inference are two fields that will be extremely profitable for investors.